| Dr William F Reid, MD | |
|
1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301-3223 | |
| (601) 483-5322 | |
| (601) 693-8081 |
| Full Name | Dr William F Reid |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 49 Years |
| Location | 1600 22nd Ave, Meridian, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760469340 | NPI | - | NPPES |
| 00116454 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 07934 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Meridian, MS | Home health agency |
| Sta Home Health And Hospice | Carthage, MS | Home health agency |
| Anderson Regional Medical Ctr | Meridian, MS | Hospital |
| Neshoba County General Hospital | Philadelphia, MS | Hospital |
| Anderson Regional Medical Center South Campus | Meridian, MS | Hospital |
| Rush Foundation Hospital | Meridian, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joel T Callahan Thomas H Greer Jr And A Gary Boone Ptr | 0143390146 | 18 |
News Archive
What happens on the day before a colonoscopy may be just as important as the colon-screening test itself.
High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.
Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
"Calculating the number of hungry people around the world at any given moment, let alone predicting how that number is likely to change in the future, is no easy task," Reuters reports in an article examining the numerous challenges of estimating the number of undernourished people worldwide and noting the U.N. Food and Agriculture Organization (FAO) is expected to release new data and methodology in October "as part of its annual report on food insecurity."
› Verified 7 days ago
| Entity Name | Anderson Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972720175 PECOS PAC ID: 4284548025 Enrollment ID: O20031117000522 |
News Archive
What happens on the day before a colonoscopy may be just as important as the colon-screening test itself.
High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.
Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
"Calculating the number of hungry people around the world at any given moment, let alone predicting how that number is likely to change in the future, is no easy task," Reuters reports in an article examining the numerous challenges of estimating the number of undernourished people worldwide and noting the U.N. Food and Agriculture Organization (FAO) is expected to release new data and methodology in October "as part of its annual report on food insecurity."
› Verified 7 days ago
| Entity Name | Joel T Callahan Thomas H Greer Jr & A Gary Boone Ptr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932248853 PECOS PAC ID: 0143390146 Enrollment ID: O20080603000365 |
News Archive
What happens on the day before a colonoscopy may be just as important as the colon-screening test itself.
High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.
Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
"Calculating the number of hungry people around the world at any given moment, let alone predicting how that number is likely to change in the future, is no easy task," Reuters reports in an article examining the numerous challenges of estimating the number of undernourished people worldwide and noting the U.N. Food and Agriculture Organization (FAO) is expected to release new data and methodology in October "as part of its annual report on food insecurity."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William F Reid, MD 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301-5149 Ph: (601) 483-5322 | Dr William F Reid, MD 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301-3223 Ph: (601) 483-5322 |
News Archive
What happens on the day before a colonoscopy may be just as important as the colon-screening test itself.
High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.
Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
"Calculating the number of hungry people around the world at any given moment, let alone predicting how that number is likely to change in the future, is no easy task," Reuters reports in an article examining the numerous challenges of estimating the number of undernourished people worldwide and noting the U.N. Food and Agriculture Organization (FAO) is expected to release new data and methodology in October "as part of its annual report on food insecurity."
› Verified 7 days ago
Charandle S Jordan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1314 19th Ave, Meridian, MS 39301 Phone: 601-483-0011 | |
Dr. Frederick T Duggan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301 Phone: 601-483-5322 Fax: 601-581-2289 | |
Christopher W Swift, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1314 19th Ave, Meridian, MS 39301 Phone: 601-703-4078 | |
Dr. Adam M Parker, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-484-6700 | |
Dr. Ruba F. Barakat, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Meridian, MS 39301 Phone: 601-483-5322 Fax: 601-581-2289 | |
Dr. William Greg Thaggard, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000 Fax: 601-553-6746 | |
Dr. Vincent Craig Dungan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Suite 1d, Meridian, MS 39301 Phone: 601-703-9541 Fax: 601-703-9947 |